Predict your next investment

Extend company logo
Venture Capital
extend-tt.vc

Investments

1

About Extend

Extend operates a biotechnology hub connecting academic research to the market within the biotech sector. The company identifies targets and develops therapeutic approaches from academic research through a drug discovery process to create start-ups. It was founded in 2022 and is based in Rome, Italy.

Headquarters Location

Via Alessandria 220

Rome, 00198,

Italy

Are you an investor?
Submit your portfolio details now to be considered in our investor rankings.

Extend Investments

1 Investments

Extend has made 1 investments. Their latest investment was in Aptadir Therapeutics as part of their Pre-Seed on September 24, 2024.

CBI Logo

Extend Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

9/24/2024

Pre-Seed

Aptadir Therapeutics

$1.6M

Yes

2

Date

9/24/2024

Round

Pre-Seed

Company

Aptadir Therapeutics

Amount

$1.6M

New?

Yes

Co-Investors

Sources

2

Loading...

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.